島根大学医学部眼科学講座
Presentation at the 2nd ROCK Ocular Conference, Tokyo
2025.12.06
I had the opportunity to attend and present my research at the 2nd ROCK Ocular Conference,
organized by KOWA Company, Ltd., held in Tokyo on December 6, 2025.
My presentation focused on the impact of the Rho-kinase inhibitor Ripasudil on Schlemm’s canal morphology.
During the conference, I presented our findings on the histological changes
in the aqueous humor outflow pathway and discussed their potential clinical relevance for improving glaucoma treatment.
The audience included researchers, clinicians, and specialists from across Japan,
and I was honored to receive positive feedback and insightful questions.
Participating in this conference was a valuable experience
that strengthened my motivation to continue advancing my research.
I am sincerely grateful to my supervisors for their continuous support and guidance.
Aysha Siddika Mukta
PhD student, Department of Ophthalmology
